These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

262 related articles for article (PubMed ID: 26794211)

  • 1. Biological therapy increases the health-related quality of life in patients with inflammatory bowel disease in a clinical setting.
    Holdam AS; Bager P; Dahlerup JF
    Scand J Gastroenterol; 2016; 51(6):706-11. PubMed ID: 26794211
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The cost-effectiveness of biologic versus non-biologic treatments and the health-related quality of life among a sample of patients with inflammatory bowel disease in a tertiary care center in Saudi Arabia.
    AlRuthia Y; Almadi M; Aljebreen A; Azzam N; Alsharif W; Alrasheed H; Almuaythir G; Saeed M; HajkhderMullaissa B; Alharbi O
    J Med Econ; 2020 Oct; 23(10):1102-1110. PubMed ID: 32619388
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Serum Concentration of Anti-TNF Antibodies, Adverse Effects and Quality of Life in Patients with Inflammatory Bowel Disease in Remission on Maintenance Treatment.
    Brandse JF; Vos LM; Jansen J; Schakel T; Ponsioen CI; van den Brink GR; D'Haens GR; Löwenberg M
    J Crohns Colitis; 2015 Nov; 9(11):973-81. PubMed ID: 26116557
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Predictive value of early restoration of quality of life in Crohn's disease patients receiving antitumor necrosis factor agents.
    Herrera-deGuise C; Casellas F; Robles V; Navarro E; Borruel N
    J Gastroenterol Hepatol; 2015 Feb; 30(2):286-91. PubMed ID: 25302652
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Sustained improvement in health-related quality of life measures in patients with inflammatory bowel disease receiving prolonged anti-tumor necrosis factor therapy.
    Sherman M; Tsynman DN; Kim A; Arora J; Pietras T; Messing S; St Hilaire L; Yoon S; Decross A; Shah A; Saubermann L
    J Dig Dis; 2014 Apr; 15(4):174-9. PubMed ID: 24373601
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Benefit of Earlier Anti-TNF Treatment on IBD Disease Complications?
    Nuij V; Fuhler GM; Edel AJ; Ouwendijk RJ; Rijk MC; Beukers R; Quispel R; van Tilburg AJ; Tang TJ; Smalbraak H; Bruin KF; Lindenburg F; Peyrin-Biroulet L; van der Woude CJ;
    J Crohns Colitis; 2015 Nov; 9(11):997-1003. PubMed ID: 26223842
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effect of intestinal resection on quality of life in Crohn's disease.
    Wright EK; Kamm MA; De Cruz P; Hamilton AL; Ritchie KJ; Krejany EO; Gorelik A; Liew D; Prideaux L; Lawrance IC; Andrews JM; Bampton PA; Sparrow MP; Florin TH; Gibson PR; Debinski H; Gearry RB; Macrae FA; Leong RW; Kronborg I; Radford-Smith G; Selby W; Johnston MJ; Woods R; Elliott PR; Bell SJ; Brown SJ; Connell WR; Desmond PV
    J Crohns Colitis; 2015 Jun; 9(6):452-62. PubMed ID: 25855073
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Adalimumab improves patient-reported outcomes and reduces indirect costs in patients with moderate to severe Crohn's disease: results from the CARE trial.
    Louis E; Löfberg R; Reinisch W; Camez A; Yang M; Pollack PF; Chen N; Chao J; Mulani PM
    J Crohns Colitis; 2013 Feb; 7(1):34-43. PubMed ID: 22480772
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Short health scale: A valid measure of health-related quality of life in Korean-speaking patients with inflammatory bowel disease.
    Park SK; Ko BM; Goong HJ; Seo JY; Lee SH; Baek HL; Lee MS; Park DI
    World J Gastroenterol; 2017 May; 23(19):3530-3537. PubMed ID: 28596689
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effects of adalimumab maintenance therapy on health-related quality of life of patients with Crohn's disease: patient-reported outcomes of the CHARM trial.
    Loftus EV; Feagan BG; Colombel JF; Rubin DT; Wu EQ; Yu AP; Pollack PF; Chao J; Mulani P
    Am J Gastroenterol; 2008 Dec; 103(12):3132-41. PubMed ID: 18853973
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The Short Inflammatory Bowel Disease Questionnaire: a quality of life instrument for community physicians managing inflammatory bowel disease. CCRPT Investigators. Canadian Crohn's Relapse Prevention Trial.
    Irvine EJ; Zhou Q; Thompson AK
    Am J Gastroenterol; 1996 Aug; 91(8):1571-8. PubMed ID: 8759664
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Health-related quality of life improves during one year of medical and surgical treatment in a European population-based inception cohort of patients with inflammatory bowel disease--an ECCO-EpiCom study.
    Burisch J; Weimers P; Pedersen N; Cukovic-Cavka S; Vucelic B; Kaimakliotis I; Duricova D; Bortlik M; Shonová O; Vind I; Avnstrøm S; Thorsgaard N; Krabbe S; Andersen V; Dahlerup JF; Kjeldsen J; Salupere R; Olsen J; Nielsen KR; Manninen P; Collin P; Katsanos KH; Tsianos EV; Ladefoged K; Lakatos L; Ragnarsson G; Björnsson E; Bailey Y; O'Morain C; Schwartz D; Odes S; Valpiani D; Boni MC; Jonaitis L; Kupcinskas L; Turcan S; Barros L; Magro F; Lazar D; Goldis A; Nikulina I; Belousova E; Fernandez A; Sanroman L; Almer S; Zhulina Y; Halfvarson J; Arebi N; Diggory T; Sebastian S; Lakatos PL; Langholz E; Munkholm P;
    J Crohns Colitis; 2014 Sep; 8(9):1030-42. PubMed ID: 24560877
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Negative Screening Does Not Rule Out the Risk of Tuberculosis in Patients with Inflammatory Bowel Disease Undergoing Anti-TNF Treatment: A Descriptive Study on the GETAID Cohort.
    Abitbol Y; Laharie D; Cosnes J; Allez M; Nancey S; Amiot A; Aubourg A; Fumery M; Altwegg R; Michetti P; Chanteloup E; Seksik P; Baudry C; Flamant M; Bouguen G; Stefanescu C; Bourrier A; Bommelaer G; Dib N; Bigard MA; Viennot S; Hébuterne X; Gornet JM; Marteau P; Bouhnik Y; Abitbol V; Nahon S;
    J Crohns Colitis; 2016 Oct; 10(10):1179-85. PubMed ID: 27402916
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The Short Health Scale: a valid and reliable measure of health related quality of life in English speaking inflammatory bowel disease patients.
    McDermott E; Keegan D; Byrne K; Doherty GA; Mulcahy HE
    J Crohns Colitis; 2013 Sep; 7(8):616-21. PubMed ID: 22921528
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Health-related quality of life in patients with inflammatory bowel disease: a Tunisian study.
    Mnif L; Mzid A; Amouri A; Chtourou L; Tahri N
    Tunis Med; 2010 Dec; 88(12):933-6. PubMed ID: 21136364
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Tuberculosis in Anti-Tumour Necrosis Factor-treated Inflammatory Bowel Disease Patients After the Implementation of Preventive Measures: Compliance With Recommendations and Safety of Retreatment.
    Carpio D; Jauregui-Amezaga A; de Francisco R; de Castro L; Barreiro-de Acosta M; Mendoza JL; Mañosa M; Ollero V; Castro B; González-Conde B; Hervías D; Sierra Ausin M; Sancho Del Val L; Botella-Mateu B; Martínez-Cadilla J; Calvo M; Chaparro M; Ginard D; Guerra I; Maroto N; Calvet X; Fernández-Salgado E; Gordillo J; Rojas Feria M;
    J Crohns Colitis; 2016 Oct; 10(10):1186-93. PubMed ID: 26802085
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Health-related quality of life in paediatric patients with inflammatory bowel disease related to disease activity.
    Haapamäki J; Roine RP; Sintonen H; Kolho KL
    J Paediatr Child Health; 2011 Nov; 47(11):832-7. PubMed ID: 21435075
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Efficacy and effectiveness of biologic therapy in inflammatory bowel disease. EFIFECT study].
    Ginard D; Khorrami S; Pérez-Carazo L; Tavío-Hernández E; López-Sanromán A; García-Alvarado M; Muñoz F; Ibáñez-Samaniego L; Marín-Jiménez I; Guevara J; Casellas F
    Gastroenterol Hepatol; 2016; 39(6):369-76. PubMed ID: 27005800
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Health-related quality of life in inflammatory bowel disease in a European-wide population-based cohort 10 years after diagnosis.
    Huppertz-Hauss G; Høivik ML; Langholz E; Odes S; Småstuen M; Stockbrugger R; Hoff G; Moum B; Bernklev T
    Inflamm Bowel Dis; 2015 Feb; 21(2):337-44. PubMed ID: 25569735
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Crohn's disease and ulcerative colitis. Occurrence, course and prognosis during the first year of disease in a European population-based inception cohort.
    Burisch J
    Dan Med J; 2014 Jan; 61(1):B4778. PubMed ID: 24393595
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.